Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)

Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone Fibroblast growth factor‐23 (FGF23). Anemia, elevated FGF23, and elevated serum phosphate are significant mortality risk factors for patients with chronic kidney disease (CKD). However, the contribution of anemia to overall ci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Physiol Rep
Main Authors: Noonan, Megan L., Clinkenbeard, Erica L., Ni, Pu, Swallow, Elizabeth A., Tippen, Samantha P., Agoro, Rafiou, Allen, Matthew R., White, Kenneth E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261757/
https://ncbi.nlm.nih.gov/pubmed/32476270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.14434
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados